Neuralink announced significant advances to its brain-computer interface technology, revealing that more than 10k individuals have joined the waiting list for the company’s Telepathy brain chip. The startup also unveiled a next-generation surgical robot that dramatically reduces the time required to insert neural threads into the brain.
Updated surgical robot completes thread insertion in just 1.5 seconds, a substantial improvement over the 17 seconds required by the current model. Advancement could streamline the surgical process and potentially reduce procedure times for patients receiving the Telepathy implant.
Beyond speed, Neuralink’s engineers expanded the robot’s capabilities. Device now reaches depths exceeding 50mm from the brain’s surface, allowing access to previously unreachable areas. Additionally, the surgical robot achieves compatibility with 99% of the global population, addressing previous limitations in anatomical variability.
Production efficiency has improved alongside technical performance. Neuralink reduced needle cartridge manufacturing costs by 95% compared to previous versions, which could affect the overall economics of scaling the technology.
DJ Seo, Neuralink co-founder, emphasized the company’s commitment to vertical integration. “One thing we’ll continue to invest tons and tons of money towards is vertically integrating. Pretty much all the things you saw we build in-house,” DJ stated. The company maintains its own construction team and is building custom facilities at its Austin headquarters, Neuralink’s $14.7 million investment in a 37-acre campus.
Neuralink’s vertical integration spans microfabrication, implant manufacturing, robotics, surgery, pathology, animal care, neuroengineering, and imaging. This approach grants the company control over its entire production pipeline, from component creation to surgical implementation.
What’s next for brain-computer interface technology? combination of faster surgical procedures, broader population compatibility, and reduced manufacturing costs positions Neuralink to potentially scale its operations. However, the company must still navigate regulatory requirements and demonstrate long-term safety before the Telepathy brain chip becomes widely available.
For now, those 10,000 individuals on the waiting list represent growing interest in neural interface technology.
Related Post
Neuralink Brain Implant Allows ALS Patient to Control Robotic Arm Through Thought Alone
Neuralink Summer Demos Robot Hands Control via Brain Interface, Plans Million-Bit Communication
Neuralink Implants Telepathy Chip in 6th Patient, Enables Mind-Controlled Computing